Tel：+86-18874232226 WhatsApp：+86-18874232226 E-mail：lisa@qankorey.com

A Global Pioneer to Detect Amyloid-β(Aβ) by Urine

MORE +

湖南乾康科技有限公司

MORE +

scroll down

One Step Dementia Risk Test Kit

First Globally: CE-marked

Usage: Risk alert of dementia

Fast test: read in 10 Minutes

Non-invasive: 4 drops fresh urine specimen

Clinical Performance: Sensitivity: 79.14%, Specificity: 91.03%:

Applicable People: Recommended age 45 years and above

Learn More

One Step Dementia Risk Test Kit

CE, NMPA, MDA

Rapid results within 10 minutes

Non-invasive, no need machine

Sensitivity 79.14%, Specificity 91.03%

Suitable for screening high risk patients aged 45+

Learn More

One Step Dementia Risk Test Kit

Early screening: Risk alert of Dementia

First Globally: CE-marked (IVDD 98/79/EC)

Non-invasive: Fresh midstream urine specimen

Easy to perform: 100 µL (4 drops) volume

Rapid results: read in 10 Minutes

Clinically Validated: Sensitivity 79.14%, Specificity 91.03%

Learn More

One Step Dementia Risk Test Kit

First Globally: CE-marked

Usage: Risk alert of dementia

Fast test: read in 10 Minutes

Non-invasive: 4 drops fresh urine specimen

Clinical Performance: Sensitivity: 79.14%, Specificity: 91.03%:

Applicable People: Recommended age 45 years and above

View Details

International scientific research team

Many researchers, including Professor Baijun Gu Qankorey Life Science R&D Center, Chief Scientist of Qankorey Technology, and Colin Masters, Chief Scientific Advisor of Qankorey Technology.

→

Qankorey Life Science R&D Center

Qankorey Life International R & D Center

Including the Qankorey Life Science (Changsha) R&D Center and Qankorey Life Science (Melbourne) Research Center, we provide comprehensive solutions for the prevention, screening, diagnosis, and treatment of Alzheimer's disease.

→

Industry-university-research cooperation

We have established cooperation with AIBL and Florey research institutes abroad, as well as with various research institutes and hospitals such as Huashan Hospital and Ruijin Hospital of Fudan University in China.

→

Qualifications and Patents

Undertaking more than ten major special projects of the Ministry of Science and Technology and provincial and municipal governments, possessing more than 160 intellectual property rights such as patents and software copyrights.

→

R&D and Manufacturing

A biotechnology enterprise that focuses on the research of key technologies for Alzheimer's disease (AD), a global medical challenge. It provides full industry chain services in research and development, production, and sales, achieving full process management of Alzheimer's disease.

Globalization Development

Accelerate the internationalization strategy and forge a new landscape in the Alzheimer's Disease (AD) market.

Our business footprint has expanded across Asia, Europe, Oceania and beyond. We are consistently boosting brand influence while advancing the international marketing strategy in a steady and prudent manner.

Join us

News And Events

2025-08-19

Qankorey's One Step Dementia Risk Test Kit Showcased at the 8th National Congress